Shots: The P-III HELP OLE study evaluates the safety & efficacy of Takhzyro (300mg, q2w) in 212 patients aged ≥12yrs. with HAE attacks for ~2.5yrs. Results: 87.4% mean reduction in […]readmore
Tags : Hereditary Angioedema Attacks
Shots: The P-III HELP OLE study evaluating the safety & efficacy of Takhzyro (300mg, q2w) in 212 patients aged ≥12yrs. with HAE attacks for ~2.5 yrs. Results: 87.4% mean reduction […]readmore
Shots: The positive recommendation is based on P-III Help Study Open-label Extension assessing Takhzyro (300mg, q2w) in 212 HAE adolescents and adults aged ≥12 yrs. The P-III Help study OLE […]readmore